Balchem Corporation (BCPC)
Total Valuation
Balchem has a market cap or net worth of $4.05 billion. The enterprise value is $4.43 billion.
| Market Cap | 4.05B |
| Enterprise Value | 4.43B |
Important Dates
The next earnings date is Friday, May 5, 2023, before market open.
| Estimated Earnings Date | May 5, 2023 |
| Ex-Dividend Date | Dec 23, 2022 |
Share Statistics
Balchem has 32.17 million shares outstanding. The number of shares has decreased by -0.76% in one year.
| Shares Outstanding | 32.17M |
| Shares Change (YoY) | -0.76% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.93% |
| Owned by Institutions (%) | 91.19% |
| Float | 31.88M |
Valuation Ratios
The trailing PE ratio is 38.70 and the forward PE ratio is 31.55. Balchem's PEG ratio is 8.29.
| PE Ratio | 38.70 |
| Forward PE | 31.55 |
| PS Ratio | 4.29 |
| Forward PS | 3.76 |
| PB Ratio | 4.31 |
| P/FCF Ratio | 45.75 |
| PEG Ratio | 8.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.64, with an EV/FCF ratio of 50.13.
| EV / Earnings | 42.08 |
| EV / Sales | 4.71 |
| EV / EBITDA | 22.64 |
| EV / EBIT | 30.79 |
| EV / FCF | 50.13 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.40 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.35 |
| Debt / FCF | 5.21 |
Financial Efficiency
Return on equity (ROE) is 11.70% and return on invested capital (ROIC) is 17.70%.
| Return on Equity (ROE) | 11.70% |
| Return on Assets (ROA) | 7.00% |
| Return on Capital (ROIC) | 17.70% |
| Revenue Per Employee | $681,880 |
| Profits Per Employee | $76,242 |
| Employee Count | 1,382 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 6.28 |
Taxes
In the past 12 months, Balchem has paid $28.38 million in taxes.
| Income Tax | 28.38M |
| Effective Tax Rate | 21.22% |
Stock Price Statistics
The stock price has decreased by -9.58% in the last 52 weeks. The beta is 0.69, so Balchem's price volatility has been lower than the market average.
| Beta (1Y) | 0.69 |
| 52-Week Price Change | -9.58% |
| 50-Day Moving Average | 130.60 |
| 200-Day Moving Average | 129.98 |
| Average Volume (30 Days) | 96,300 |
Short Selling Information
The latest short interest is 251,958, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 251,958 |
| Short Previous Month | 261,628 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 2.12 |
Income Statement
In the last 12 months, Balchem had revenue of $942.36 million and earned $105.37 million in profits. Earnings per share was $3.25.
| Revenue | 942.36M |
| Gross Profit | 280.45M |
| Operating Income | 145.19M |
| Pretax Income | 133.75M |
| Net Income | 105.37M |
| EBITDA | 195.87M |
| EBIT | 144.02M |
| Earnings Per Share (EPS) | $3.25 |
Balance Sheet
The company has $72.55 million in cash and $460.61 million in debt, giving a net cash position of -$388.06 million or -$12.06 per share.
| Cash & Cash Equivalents | 72.55M |
| Total Debt | 460.61M |
| Net Cash | -388.06M |
| Net Cash Per Share | -$12.06 |
| Equity / Book Value | 938.28M |
| Book Value Per Share | 29.17 |
| Working Capital | 195.76M |
Cash Flow
In the last 12 months, operating cash flow was $138.54 million and capital expenditures -$50.08 million, giving a free cash flow of $88.45 million.
| Operating Cash Flow | 138.54M |
| Capital Expenditures | -50.08M |
| Free Cash Flow | 88.45M |
| FCF Per Share | $2.75 |
Margins
Gross margin is 29.76%, with operating and profit margins of 15.41% and 11.18%.
| Gross Margin | 29.76% |
| Operating Margin | 15.41% |
| Pretax Margin | 14.19% |
| Profit Margin | 11.18% |
| EBITDA Margin | 20.78% |
| EBIT Margin | 15.28% |
| FCF Margin | 9.39% |
Dividends & Yields
This stock pays an annual dividend of $0.71, which amounts to a dividend yield of 0.56%.
| Dividend Per Share | $0.71 |
| Dividend Yield | 0.56% |
| Earnings Yield | 2.60% |
| FCF Yield | 2.19% |
| Dividend Growth (YoY) | 10.94% |
| Payout Ratio | 21.60% |
| Buyback Yield | 0.76% |
| Shareholder Yield | 1.33% |
Analyst Forecast
The average price target for Balchem is $153.00, which is 21.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $153.00 |
| Price Target Difference | 21.64% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 3:2.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 3:2 |